GENESIS Pharma
Michas Nikolaos is a Financial Analyst at Genesis Pharma with previous experience at PwC Greece as a Senior Audit Associate. Prior to that, Michas worked at Εθνική Ασφαλιστική in the sales department. Michas holds a Master's Degree in Applied accounting and auditing from Ethnikon kai Kapodistriakon Panepistimion Athinon, as well as a Bachelor's Degree in Economics from the same institution. Additionally, Michas obtained an Accountancy Professional Qualification in Auditing & Accounting from the Institute of Certified Public Accountants of Greece.
Previous companies
This person is not in any offices
GENESIS Pharma
GENESIS Pharma is a regional biopharma company focused on the commercialization of innovative pharmaceutical products for severe and rare diseases in Central and Eastern Europe. Founded in 1997 in Greece, GENESIS Pharma S.A. was among the first pharmaceutical companies in Europe to specialize in the marketing, sales and distribution of biopharmaceutical products. In 1999, business activities were expanded in Cyprus through the creation of GENESIS Pharma (Cyprus) Ltd, and later on, in markets of Southeast Europe. GENESIS Pharma (Cyprus) Ltd, an affiliate (sister) company, now operates in Central and Eastern Europe, through its subsidiaries in Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia (EU) as well as North Macedonia and Serbia (Non-EU). GENESIS Pharma maintains a strong portfolio in therapeutic areas with high unmet medical need through long standing strategic alliances with leading international pharma companies committed to cutting-edge R&D as well as biopharma companies with disruptive innovations for the development of targeted, specialized treatments for orphan diseases. For more information, please visit www.genesispharmagroup.com and www.genesispharma.com